EUVIMEDEUVIMED entdecken
Kontrollierte klinische StudieOpen Access · CC BY 4.0

Promoter hypermethylation of RARB and GSTP1 genes in plasma cell‐free DNA as breast cancer biomarkers in Peruvian women

Pierina Danos, Stefano Giannoni-Luza, Alexis Germán Murillo Carrasco iD, Oscar Acosta, Maria Luisa Guevara-Fujita, José Manuel Cotrina Concha, Henry Guerra Miller, Joseph Pinto Oblitas, Alfredo Aguilar Cartagena, Jhajaira M Araujo, Ricardo Fujita iD, José Luis Buleje Sono iD

Molecular Genetics & Genomic Medicine · 2023

DOI: 10.1002/mgg3.2260 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift Molecular Genetics & Genomic Medicine, 2023. Verfasst von Pierina Danos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima, Peru. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oncosalud-AUNA, Origenetica SAC, Programa Nacional de Innovación para la Competitividad y Productividad - Innóvate Perú.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Promoter hypermethylation is one of the enabling mechanisms of hallmarks of cancer. Tumor suppressor genes like RARB and GSTP1 have been reported as hypermethylated in breast cancer tumors compared with normal tissues in several populations. This case–control study aimed to determine the association between the promoter methylation ratio (PMR) of RARB and GSTP1 genes (separately and as a group) with breast cancer and its clinical‐pathological variables in Peruvian patients, using a liquid biopsy approach.

Methods

A total of 58 breast cancer patients and 58 healthy controls, matched by age, participated in the study. We exacted cell‐free DNA (cfDNA) from blood plasma and converted it by bisulfite salts. Methylight PCR was performed to obtain the PMR value of the studied genes. We determined the association between PMR and breast cancer, in addition to other clinicopathological variables. The sensitivity and specificity of the PMR of these genes were obtained.

Results

A significant association was not found between breast cancer and the RARB PMR (OR = 1.90; 95% CI [0.62–6.18]; p = 0.210) or the GSTP1 PMR (OR = 6.57; 95% CI [0.75–307.66]; p = 0.114). The combination of the RARB + GSTP1 PMR was associated with breast cancer (OR = 2.81; 95% CI [1.02–8.22]; p = 0.026), controls under 50 years old ( p = 0.048), patients older than 50 ( p = 0.007), and postmenopausal ( p = 0.034). The PMR of both genes showed a specificity of 86.21% and a sensitivity of 31.03%.

Conclusion

Promoter hypermethylation of RARB + GSTP1 genes is associated with breast cancer, older age, and postmenopausal Peruvian patients. The methylated promoter of the RARB + GSTP1 genes needs further validation to be used as a biomarker for liquid biopsy and as a recommendation criterion for additional tests in asymptomatic women younger than 50 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsFemaleHumansMiddle AgedBiomarkers, TumorBreastCase-Control StudiesDNA MethylationGlutathione S-Transferase piPeruReceptors, Retinoic Acid

Stichwörter der Autor:innen

GSTP1MethylightRARBPMRbreast cancercfDNAliquid biopsy

Substanzen

Biomarkers, TumorGlutathione S-Transferase piGSTP1 protein, humanretinoic acid receptor betaReceptors, Retinoic Acid

Autor:innen und Institutionen

  • Centro de Genética y Biología Molecular, Universidad de San Martín de Porres, Lima, Peru.
  • Facultad de Medicina Humana, Universidad de San Martín de Porres, Chiclayo, Peru.
  • Facultad de Farmacia y Bioquímica, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru.
  • Oncosalud-Auna, Lima, Peru.

ORCID-Profile: Alexis Germán Murillo Carrasco, Ricardo Fujita, José Luis Buleje Sono

Förderung

  • Oncosalud-AUNA
  • Origenetica SAC
  • Programa Nacional de Innovación para la Competitividad y Productividad - Innóvate Perú
  • Universidad de San Martín de Porres, Facultad de Medicina Humana

Zitieren

APA

Danos, P., Giannoni-Luza, S., Murillo Carrasco, A. G., Acosta, O., Guevara-Fujita, M. L., Cotrina Concha, J. M., Guerra Miller, H., Pinto Oblitas, J., Aguilar Cartagena, A., Araujo, J. M., Fujita, R., & Buleje Sono, J. L. (2023). Promoter hypermethylation of RARB and GSTP1 genes in plasma cell‐free DNA as breast cancer biomarkers in Peruvian women. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2260

Vancouver

Danos P, Giannoni-Luza S, Murillo Carrasco AG, Acosta O, Guevara-Fujita ML, Cotrina Concha JM, et al. Promoter hypermethylation of RARB and GSTP1 genes in plasma cell‐free DNA as breast cancer biomarkers in Peruvian women. Molecular Genetics & Genomic Medicine. 2023. doi:10.1002/mgg3.2260

BibTeX
@article{Danos2023,
  author = {Danos, Pierina and Giannoni-Luza, Stefano and Murillo Carrasco, Alexis Germán and Acosta, Oscar and Guevara-Fujita, Maria Luisa and Cotrina Concha, José Manuel and Guerra Miller, Henry and Pinto Oblitas, Joseph and Aguilar Cartagena, Alfredo and Araujo, Jhajaira M and Fujita, Ricardo and Buleje Sono, José Luis},
  title = {Promoter hypermethylation of RARB and GSTP1 genes in plasma cell‐free DNA as breast cancer biomarkers in Peruvian women},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2023},
  doi = {10.1002/mgg3.2260}
}
Kostenlos starten →